Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT06841705
Brief Title:
Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Official Title:
Early Concomitant Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Acronym:
EVITA
Study:
NCT06841705
Protocol Section:
NCT06841705